De Meester J - Search Results

1

Six newly identified HLA-DRB alleles: DRB1*1121, *1419, *1420, *1421, DRB3*0203 and DRB5*0103.

Verduyn W, Anholts JD, Versluis LF, Parlevliet J, Drabbels J, De Meester J, Tilanus MG, Doxiadis II, Giphart MJ, Schreuder GM. Verduyn W, et al. Among authors: de meester j. Tissue Antigens. 1996 Aug;48(2):80-6. doi: 10.1111/j.1399-0039.1996.tb02611.x. Tissue Antigens. 1996. PMID: 8883296

2

Repeated HLA mismatches in cadaveric renal transplantation: is it safe to transplant?

Doxiadis II, de Lange P, D'Amaro J, de Meester J, Schreuder GM, Claas FH. Doxiadis II, et al. Among authors: de lange p, de meester j. Transplant Proc. 1997 Feb-Mar;29(1-2):1408-9. doi: 10.1016/s0041-1345(96)00612-4. Transplant Proc. 1997. PMID: 9123357 No abstract available.

3

The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant.

Doxiadis II, De Meester J, Smits JM, Witvliet M, de Lange P, Persijn GG, Claas FH. Doxiadis II, et al. Among authors: de lange p, de meester j. Clin Transpl. 1998:115-20. Clin Transpl. 1998. PMID: 10503090

4

Acceptable HLA mismatches for highly immunized patients.

Claas FH, De Meester J, Witvliet MD, Smits JM, Persijn GG, Doxiadis II. Claas FH, et al. Among authors: de meester j. Rev Immunogenet. 1999;1(3):351-8. Rev Immunogenet. 1999. PMID: 11256426 Review.

5

Efficiency of special programs for highly sensitized patients within eurotransplant.

Doxiadis II, De Meester J, Persijn GG, Claas FH. Doxiadis II, et al. Among authors: de meester j. Transplant Proc. 2001 Feb-Mar;33(1-2):835-6. doi: 10.1016/s0041-1345(00)02337-x. Transplant Proc. 2001. PMID: 11267088 No abstract available.

6

Renal transplantation of highly sensitised patients via prioritised renal allocation programs. Shorter waiting time and above-average graft survival.

De Meester J, Doxiadis II, Persijn GG, Claas FH. De Meester J, et al. Nephron. 2002 Sep;92(1):111-9. doi: 10.1159/000064480. Nephron. 2002. PMID: 12187093

7

Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.

Stobbe I, van der Meer-Prins EM, de Lange P, Oudshoorn M, De Meester J, Doxiadis II, Claas FH. Stobbe I, et al. Among authors: de lange p, de meester j. Transplantation. 2000 Jul 15;70(1):157-61. Transplantation. 2000. PMID: 10919594

8

Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins.

de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, Doxiadis II, Persijn GG. de Boer J, et al. Among authors: de meester j. Transpl Int. 1999;12(6):447-53. doi: 10.1007/s001470050256. Transpl Int. 1999. PMID: 10654357 Clinical Trial.

9

Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group.

Deng MC, De Meester JM, Smits JM, Heinecke J, Scheld HH. Deng MC, et al. Among authors: de meester jm. BMJ. 2000 Sep 2;321(7260):540-5. doi: 10.1136/bmj.321.7260.540. BMJ. 2000. PMID: 10968814 Free PMC article.

10

Demand, supply and allocation in Eurotransplant.

Persijn GG, De Meester JM. Persijn GG, et al. Among authors: de meester jm. Ann Transplant. 1997;2(1):26-33. Ann Transplant. 1997. PMID: 9869838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters